Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Anu Haveri, Nina Ekström, Anna Solastie, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 3202-3213
Open Access | Times Cited: 90

Showing 26-50 of 90 citing articles:

Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves
Hatairat Lerdsamran, Anek Mungaomklang, Sopon Iamsirithaworn, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0263316-e0263316
Open Access | Times Cited: 12
Point-of-Care Diagnostic Tools for Surveillance of SARS-CoV-2 Infections
Dhanasekaran Sakthivel, David Jose Delgado-Diaz, Laura McArthur, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 16
High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020–2021
Timothée Dub, Anna Solastie, Lotta Hagberg, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Underreporting of SARS-CoV-2 infections during the first wave of the 2020 COVID-19 epidemic in Finland—Bayesian inference based on a series of serological surveys
Tuomo Nieminen, Kari Auranen, Sangita Kulathinal, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0282094-e0282094
Open Access | Times Cited: 5
Effects of COVID-19 Mandates on College Students’ Exercise Experiences and Psychosocial Health
Maria Kosma, Moo Song Kim, Dal-Hyun Moon, et al.
International Journal of Sport Exercise and Health Research (2023) Vol. 7, Iss. 1, pp. 9-16
Open Access | Times Cited: 5
Characterization of SARS-CoV-2 Convalescent Patients’ Serological Repertoire Reveals High Prevalence of Iso–RBD Antibodies
Nicholas C. Curtis, Seungmin Shin, Andrew P. Hederman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Underreporting of SARS-CoV-2 infections during the first wave of the 2020 COVID-19 epidemic in Finland - Bayesian inference based on a series of serological surveys
Tuomo Nieminen, Kari Auranen, Sangita Kulathinal, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, et al.
JCI Insight (2023) Vol. 8, Iss. 8
Open Access | Times Cited: 4
Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
Robert Flisiak, Małgorzata Pawłowska, Magdalena Rogalska, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1325-1325
Open Access | Times Cited: 11
Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
Olivier Épaulard, Marlyse Buisson, Benjamin Némoz, et al.
Journal of Infection (2021) Vol. 84, Iss. 3, pp. 418-467
Open Access | Times Cited: 9
Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology
Sundararaj Stanleyraj Jeremiah, Kei Miyakawa, Akihide Ryo
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 6
SARS-CoV-2 antibody response after BNT162b2 mRNA vaccine in healthcare workers: Nine-month of follow-up
Franco Mastroianni, Pietro Guida, Grazia Bellanova, et al.
Vaccine X (2022) Vol. 11, pp. 100175-100175
Open Access | Times Cited: 6
Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
Nina Ekström, Anu Haveri, Anna Solastie, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 12
Open Access | Times Cited: 6
Total freedom in physical activity via body schema: being for itself and being in the world
Maria Kosma
Turkish Journal of Kinesiology (2023) Vol. 9, Iss. 3, pp. 247-258
Open Access | Times Cited: 3
Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina
Božo Šušak, Vinka Mikulić, Armina Lazarević, et al.
Bosnian Journal of Basic Medical Sciences (2021)
Open Access | Times Cited: 7
Circulating IgG Levels in SARS-CoV-2 Convalescent Individuals in Cyprus
Ioannis Mamais, Apostolos Malatras, Gregory Papagregoriou, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5882-5882
Open Access | Times Cited: 7
Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
Christian M. Tegeler, Tatjana Bilich, Yacine Maringer, et al.
International Journal of Infectious Diseases (2022) Vol. 120, pp. 187-195
Open Access | Times Cited: 5
SARS-CoV-2 seroprevalence and risk factors among meat packing, produce processing, and farm workers
Melissa D. Klein, Michael Sciaudone, David B. Richardson, et al.
PLOS Global Public Health (2022) Vol. 2, Iss. 7, pp. e0000619-e0000619
Open Access | Times Cited: 5
Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses
Yajie Lin, Jiajie Zhu, Zongming Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study
Jessica H. Brehm, Alexander Spaeth, Lars Dreßler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay
Julia Klüpfel, Sandra Paßreiter, Melina Rumpf, et al.
Analytical and Bioanalytical Chemistry (2022) Vol. 415, Iss. 3, pp. 391-404
Open Access | Times Cited: 5
Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care setting
Madhura S. Rane, McKaylee Robertson, Sarah Kulkarni, et al.
Vaccine (2022) Vol. 41, Iss. 4, pp. 989-998
Open Access | Times Cited: 5
IgG antispike persistence and immunophenotype in children infected by SARS‐CoV‐2
Alberto García‐Salido, Patricia Flores‐Pérez, África González‐Murillo, et al.
Acta Paediatrica (2023) Vol. 112, Iss. 4, pp. 805-812
Open Access | Times Cited: 2
Kinetics and persistence of anti‐SARS‐CoV‐2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort
Lara Šošić, Marta Paolucci, Agathe Duda, et al.
Immunity Inflammation and Disease (2021) Vol. 10, Iss. 3
Open Access | Times Cited: 6
COVID-19 vaccine booster induces a strong CD8+ T cell response against Omicron variant epitopes in HLA-A*02:01+ individuals
Andrea Nguyen, Christopher Szeto, Demetra S.M. Chatzileontiadou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4

Scroll to top